Skip to Content
 

News: March, 2018

Study finds broken circadian clock in human tumors

Thursday, March 29th, 2018

Human tumors appear to have a broken circadian clock, researchers at Vanderbilt University Medical Center report in the journal PeerJ.

Study tracks protein’s role in stem cell function

Thursday, March 22nd, 2018

Many types of cancer cells escape the body’s effort to kill them by overexpressing MCL-1, a protein important for blocking apoptosis, or programmed cell death. A recent study by Vivian Gama, PhD and colleagues indicates that MCL-1 also helps maintain the identity and ability of stem cells to differentiate, or give rise to other kinds of cells. 

Peek named to serve on NIDDK Advisory Council

Thursday, March 22nd, 2018

Richard Peek, MD, director of the Vanderbilt Digestive Disease Research Center (VDDRC) and chief of the Division of Gastroenterology, Hepatology and Nutrition, has been appointed to serve on the advisory council of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

Boehringer Ingelheim and Vanderbilt University expand partnership to develop novel treatment approaches for cancer

Thursday, March 22nd, 2018

Boehringer Ingelheim and Vanderbilt University recently announced the expansion of their successful existing collaboration to develop novel anti-cancer compounds.

Cancer immunotherapy drugs linked with more serious heart effects

Monday, March 12th, 2018

Vanderbilt University Medical Center investigators have identified a growing number of serious and sometimes fatal cases of heart problems among cancer patients treated with some forms of immunotherapy.

Research conducted by medical students recognized at events

Monday, March 12th, 2018

Vanderbilt-Ingram Cancer Center, Meharry Medical College and Tennessee State University Cancer Partnership recently hosted the 2018 annual retreat and poster contest, “Health Disparities in Cancer Immunology & Immune Therapy.”

VICC study sheds new light on Von Hippel-Lindau syndrome

Monday, March 12th, 2018

A new study by W. Kimryn Rathmell, MD, PhD, and colleagues, reveals a gene mutation’s role in Von Hippel-Lindau syndrome, a genetically inherited disease which causes tumor growth in several organs.

Lovly earns scholarship grant for lung cancer research

Monday, March 12th, 2018

Christine Lovly, MD, PhD, assistant professor of Medicine, has received a $200,000 grant to support promising new research on lung cancer.

Awareness, education goal of new HPV initiative

Monday, March 12th, 2018

Ronald Alvarez, MD, chair of the Department of Obstetrics and Gynecology, has formed the HPV-Associated Cancer Consortium Vanderbilt (HPVACTIVE) program to raise awareness and provide community-wide education about HPV-associated cancers.